Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam R J Hoare

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Trends in Pharmacological Sciences|August 16, 2025
Potentiation of GPCR signaling by ATP and sugar monophosphatesSam R J Hoare
Current Neuropharmacology|March 24, 2009
Allosteric modulators of class B G-protein-coupled receptorsSam R J Hoare
Journal of Pharmacological and Toxicological Methods|August 19, 2017
Receptor binding kinetics equations: Derivation using the Laplace transform methodSam R J Hoare
Drug Discovery Today|April 6, 2005
Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptorsSam R J Hoare
SLAS Discovery : Advancing Life Sciences R & D|June 11, 2021
The Problems of Applying Classical Pharmacology Analysis to Modern In Vitro Drug Discovery Assays: Slow Binding Kinetics and High Target ConcentrationSam R J Hoare
Peptides|June 27, 2002
Specificity and stability of a new PTH1 receptor antagonist, mouse TIP(7-39)Sam R J Hoare, Ted B Usdin
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2005
Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational statesSarah A Nickolls, Beth Fleck, Sam R J Hoare, et al.
Scientific Reports|February 6, 2020
A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis frameworkSam R J Hoare, Paul H Tewson, Anne Marie Quinn, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2017
Pharmacologic Characterization of Valbenazine (NBI-98854) and Its MetabolitesDimitri E Grigoriadis, Evan Smith, Sam R J Hoare, et al.
Drug Discovery Today|September 27, 2019
The importance of target binding kinetics for measuring target binding affinity in drug discovery: a case study from a CRF<sub>1</sub> receptor antagonist programSam R J Hoare, Beth A Fleck, John P Williams, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|August 16, 2025
Potentiation of GPCR signaling by ATP and sugar monophosphatesSam R J Hoare
Current Neuropharmacology|March 24, 2009
Allosteric modulators of class B G-protein-coupled receptorsSam R J Hoare
Journal of Pharmacological and Toxicological Methods|August 19, 2017
Receptor binding kinetics equations: Derivation using the Laplace transform methodSam R J Hoare
Drug Discovery Today|April 6, 2005
Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptorsSam R J Hoare
SLAS Discovery : Advancing Life Sciences R & D|June 11, 2021
The Problems of Applying Classical Pharmacology Analysis to Modern In Vitro Drug Discovery Assays: Slow Binding Kinetics and High Target ConcentrationSam R J Hoare
Peptides|June 27, 2002
Specificity and stability of a new PTH1 receptor antagonist, mouse TIP(7-39)Sam R J Hoare, Ted B Usdin
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2005
Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational statesSarah A Nickolls, Beth Fleck, Sam R J Hoare, et al.
Scientific Reports|February 6, 2020
A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis frameworkSam R J Hoare, Paul H Tewson, Anne Marie Quinn, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2017
Pharmacologic Characterization of Valbenazine (NBI-98854) and Its MetabolitesDimitri E Grigoriadis, Evan Smith, Sam R J Hoare, et al.
Drug Discovery Today|September 27, 2019
The importance of target binding kinetics for measuring target binding affinity in drug discovery: a case study from a CRF<sub>1</sub> receptor antagonist programSam R J Hoare, Beth A Fleck, John P Williams, et al.
Pageof 3